{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:51:19Z","timestamp":1790070679575,"version":"4.0.1"},"reference-count":40,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T00:00:00Z","timestamp":1476230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81072641"],"award-info":[{"award-number":["81072641"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81273499"],"award-info":[{"award-number":["81273499"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473205"],"award-info":[{"award-number":["81473205"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81400359"],"award-info":[{"award-number":["81400359"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Physiologica"],"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>The transcriptional cofactor receptor\u2010interacting protein 140 (<jats:styled-content style=\"fixed-case\">RIP<\/jats:styled-content>140) is known as a deleterious regulator of cardiac mitochondrial function and energy metabolic homeostasis. This study revealed that <jats:styled-content style=\"fixed-case\">RIP<\/jats:styled-content>140 repressed Sirtuin 3 (<jats:styled-content style=\"fixed-case\">SIRT<\/jats:styled-content>3), a mitochondrial deacetylase that plays an important role in regulating cardiac function.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">RIP<\/jats:styled-content>140 was overexpressed by adenovirus infection or was knocked down by <jats:styled-content style=\"fixed-case\">RNA<\/jats:styled-content> interference in neonatal rat cardiomyocytes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">RIP<\/jats:styled-content>140 overexpression repressed, while <jats:styled-content style=\"fixed-case\">RIP<\/jats:styled-content>140 silencing elevated the expression and activity of <jats:styled-content style=\"fixed-case\">SIRT<\/jats:styled-content>3. Ad\u2010<jats:styled-content style=\"fixed-case\">RIP<\/jats:styled-content>140 enhanced the expressions of the cardiac hypertrophic markers and increased cardiomyocyte surface area, whereas <jats:styled-content style=\"fixed-case\">SIRT<\/jats:styled-content>3 overexpression prevented the effect of Ad\u2010<jats:styled-content style=\"fixed-case\">RIP<\/jats:styled-content>140. Additionally, <jats:styled-content style=\"fixed-case\">SIRT<\/jats:styled-content>3 overexpression reversed Ad\u2010<jats:styled-content style=\"fixed-case\">RIP<\/jats:styled-content>140\u2010induced mitochondrial dysfunction and energy metabolic dysfunction, such as increase in oxidative stress, decrease in mitochondrial membrane potential and <jats:styled-content style=\"fixed-case\">ATP<\/jats:styled-content> production, as well as downregulation of mitochondrial <jats:styled-content style=\"fixed-case\">DNA<\/jats:styled-content>\u2010encoded genes and genes related to mitochondrial genome replication and transcription, mitochondrial oxidative phosphorylation and fatty acid oxidation. In contrast, <jats:styled-content style=\"fixed-case\">SIRT<\/jats:styled-content>3 silencing exacerbated <jats:styled-content style=\"fixed-case\">RIP<\/jats:styled-content>140\u2010induced cardiomyocyte hypertrophy and mitochondrial dysfunction. Furthermore, the repression of <jats:styled-content style=\"fixed-case\">SIRT<\/jats:styled-content>3 by <jats:styled-content style=\"fixed-case\">RIP<\/jats:styled-content>140 was dependent on estrogen\u2010related receptor\u2010\u03b1 (<jats:styled-content style=\"fixed-case\">ERR<\/jats:styled-content>\u03b1). The involvement of peroxisome proliferator\u2010activated receptor\u2010\u03b3 coactivator\u20101\u03b1 (<jats:styled-content style=\"fixed-case\">PGC<\/jats:styled-content>\u20101\u03b1) was ruled out of <jats:styled-content style=\"fixed-case\">SIRT<\/jats:styled-content>3 suppression by <jats:styled-content style=\"fixed-case\">RIP<\/jats:styled-content>140. <jats:styled-content style=\"fixed-case\">RIP<\/jats:styled-content>140 and <jats:styled-content style=\"fixed-case\">PGC<\/jats:styled-content>\u20101\u03b1 might act as functional antagonists on the regulation of <jats:styled-content style=\"fixed-case\">SIRT<\/jats:styled-content>3.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study indicates that suppression of <jats:styled-content style=\"fixed-case\">SIRT<\/jats:styled-content>3 by <jats:styled-content style=\"fixed-case\">RIP<\/jats:styled-content>140 facilitates the development of cardiomyocyte hypertrophy, mitochondrial dysfunction and energy metabolic dysfunction. Strategies targeting inhibition of <jats:styled-content style=\"fixed-case\">RIP<\/jats:styled-content>140 and upregulation of <jats:styled-content style=\"fixed-case\">SIRT<\/jats:styled-content>3 might improve cardiac energy metabolism and suggest therapeutic potential for heart diseases.<\/jats:p><\/jats:sec>","DOI":"10.1111\/apha.12800","type":"journal-article","created":{"date-parts":[[2016,9,10]],"date-time":"2016-09-10T13:23:28Z","timestamp":1473513808000},"page":"58-71","source":"Crossref","is-referenced-by-count":22,"title":["Receptor\u2010interacting Protein 140 represses Sirtuin 3 to facilitate hypertrophy, mitochondrial dysfunction and energy metabolic dysfunction in cardiomyocytes"],"prefix":"10.1111","volume":"220","author":[{"given":"J.","family":"You","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology National and Local United Engineering Lab of Druggability and New Drugs Evaluation School of Pharmaceutical Sciences Sun Yat\u2010Sen University Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology National and Local United Engineering Lab of Druggability and New Drugs Evaluation School of Pharmaceutical Sciences Sun Yat\u2010Sen University Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology National and Local United Engineering Lab of Druggability and New Drugs Evaluation School of Pharmaceutical Sciences Sun Yat\u2010Sen University Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy The Second Affiliated Hospital of Guangzhou Medical University Guangzhou Guangdong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Lu","sequence":"additional","affiliation":[{"name":"School of Nursing Guangdong Pharmaceutical University Guangzhou Guangdong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology National and Local United Engineering Lab of Druggability and New Drugs Evaluation School of Pharmaceutical Sciences Sun Yat\u2010Sen University Guangzhou China"},{"name":"School of Medicine Xizang Minzu University Xianyang ShaanXi China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology National and Local United Engineering Lab of Druggability and New Drugs Evaluation School of Pharmaceutical Sciences Sun Yat\u2010Sen University Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology National and Local United Engineering Lab of Druggability and New Drugs Evaluation School of Pharmaceutical Sciences Sun Yat\u2010Sen University Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery Sun Yat\u2010sen Memorial Hospital Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology National and Local United Engineering Lab of Druggability and New Drugs Evaluation School of Pharmaceutical Sciences Sun Yat\u2010Sen University Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology National and Local United Engineering Lab of Druggability and New Drugs Evaluation School of Pharmaceutical Sciences Sun Yat\u2010Sen University Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,10,12]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0803790105"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/me.2005-0227"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2010.07.009"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1210\/me.2007-0213"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2012.03.023"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.25.21.9383-9391.2005"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2006.06.008"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi901627u"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddh109"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1113\/eph8802514"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.physiol.65.092101.142528"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00243.2010"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvp418"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.202390"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.18632\/aging.100252"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0604392103"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2011.01.002"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08778"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature04634"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-121699"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-015-0493-6"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011707"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1161\/hc4501.098944"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01636-07"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-21631-2_8"},{"key":"e_1_2_7_27_1","first-page":"1787","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"14","author":"Mcmurray J.J.V.","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra063052"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvu156"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00027.2014"},{"key":"e_1_2_7_31_1","first-page":"125","article-title":"Suppression of oxidative metabolism and mitochondrial biogenesis by the transcriptional corepressor RIP140 in mouse adipocytes","volume":"116","author":"Powelka A.M.","year":"2006","journal-title":"J\u00a0Nutr"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2010.11.015"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-010-0663-9"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2010.12.016"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0603968103"},{"key":"e_1_2_7_36_1","first-page":"262","article-title":"Transcription factors in heart: promising therapeutic targets in cardiac hypertrophy","volume":"7","author":"Shrey K.","year":"2011","journal-title":"Curr Cardiol Rev"},{"key":"e_1_2_7_37_1","first-page":"2758","article-title":"Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a\u2010dependent antioxidant defense mechanisms in mice","volume":"119","author":"Sundaresan N.R.","year":"2009","journal-title":"J Clin Invest"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2010.11.003"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2010.12.013"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80611-X"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2014.05.005"}],"container-title":["Acta Physiologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapha.12800","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapha.12800","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apha.12800","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T13:01:37Z","timestamp":1695474097000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apha.12800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,12]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.1111\/apha.12800"],"URL":"https:\/\/doi.org\/10.1111\/apha.12800","archive":["Portico"],"relation":{},"ISSN":["1748-1708","1748-1716"],"issn-type":[{"value":"1748-1708","type":"print"},{"value":"1748-1716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,12]]}}}